Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Testosterone
Drug ID BADD_D02170
Description Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995] Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.[A187114,L8983,L8935,L8938,L8986,L8989,L8992,L8995] Testosterone was isolated from samples and also synthesized in 1935.[A186943]
Indications and Usage Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]
Marketing Status approved; investigational
ATC Code G03BA03
DrugBank ID DB00624
KEGG ID D00075
MeSH ID D013739
PubChem ID 6013
TTD Drug ID D06XMU
NDC Product Code 0832-1120; 65089-0050; 43598-304; 49884-418; 63629-8455; 63629-9310; 0591-2925; 38779-2936; 43647-568; 43742-1436; 73774-014; 76003-1083; 43742-1242; 0245-0871; 62332-552; 70700-112; 76420-685; 76420-687; 76420-699; 24979-130; 45802-610; 0051-8462; 64380-151; 68180-943; 69097-363; 0591-2363; 0603-7831; 0009-5020; 44132-006; 49452-7658; 64025-0010; 45802-281; 0245-0872; 0023-5992; 63629-2125; 64380-152; 66887-001; 0591-2114; 0591-2924; 0591-2926; 0591-3216; 0832-1121; 51927-0267; 70492-002; 76420-684; 0009-0074; 12875-8248; 22552-0009; 49452-7652; 60592-721; 60870-0251; 16714-967; 17139-562; 63629-2124; 68180-941; 44132-008; 48087-0113; 51552-0029; 42667-5511; 63481-183; 63629-2352; 69238-1013; 0591-3217; 0591-3524; 38779-0163; 38779-2598; 82393-113; 24979-078; 45802-366; 66887-004; 51552-0564; 62991-2150; 76420-686; 16714-969; 45802-754; 49884-510; 62332-488; 69339-158; 0591-2921; 49452-7657; 16714-968; 0023-5990
UNII 3XMK78S47O
Synonyms Testosterone | 17-beta-Hydroxy-4-Androsten-3-one | 17 beta Hydroxy 4 Androsten 3 one | Androtop | Histerone | Sterotate | Sustanon | Androderm | Testoderm | Testolin | Testopel | Testosterone Sulfate | AndroGel | 8-Isotestosterone | 8 Isotestosterone | 17-beta-Hydroxy-8 alpha-4-Androsten-3-one | 17 beta Hydroxy 8 alpha 4 Androsten 3 one | Andropatch | Testim
Chemical Information
Molecular Formula C19H28O2
CAS Registry Number 58-22-0
SMILES CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Application site vesicles12.07.01.009; 08.02.01.009; 23.03.01.0090.001081%Not Available
Application site dryness23.03.03.024; 12.07.01.011; 08.02.01.0110.001081%Not Available
Carotid artery occlusion24.04.06.008; 17.08.01.0120.000318%Not Available
Application site inflammation12.07.01.024; 08.02.01.0240.000463%Not Available
Osteopenia15.02.03.003; 14.04.04.004--Not Available
Spontaneous penile erection21.03.01.010--Not Available
Emotional distress19.04.02.0080.030009%Not Available
Gingival blister07.09.13.001--Not Available
Gingival oedema07.09.13.009; 14.05.06.018--Not Available
Sudden cardiac death08.04.01.008; 02.03.04.0160.000636%Not Available
Erythropoiesis abnormal01.07.02.010--Not Available
Left ventricular dysfunction02.04.02.0110.000182%
Left ventricular hypertrophy02.04.02.0140.000136%Not Available
Balance disorder08.01.03.081; 17.02.02.007--Not Available
Abnormal clotting factor01.01.02.005--Not Available
Impatience19.05.01.014--Not Available
Cardiac death08.04.01.007; 02.03.04.0150.000182%Not Available
Application site paraesthesia17.02.06.012; 12.07.01.026; 08.02.01.0260.000309%Not Available
Application site urticaria23.04.02.002; 12.07.01.028; 10.01.06.002; 08.02.01.0280.000463%Not Available
Contusion15.03.05.007; 24.07.06.001; 23.03.11.002; 12.01.06.001--
Prostate infection21.09.01.002; 11.01.19.001--
Musculoskeletal chest pain15.03.04.012; 22.09.01.001--
Deep vein thrombosis24.01.02.0030.070069%Not Available
Lacunar infarction24.04.06.009; 17.08.01.0160.001000%Not Available
Cardiopulmonary failure22.02.06.004; 02.05.01.0040.000182%Not Available
Blood pressure inadequately controlled24.06.01.0070.000091%Not Available
Prostatomegaly21.04.01.0020.000663%Not Available
Acute coronary syndrome02.02.02.015; 24.04.04.0110.000727%Not Available
Gastrointestinal hypomotility07.02.02.005--Not Available
Lymphatic disorder01.09.01.003--Not Available
The 14th Page    First    Pre   14 15 16 17 18    Next   Last    Total 19 Pages